What does APOTHEEK STALPAERT do?

APOTHEEK STALPAERT is a pharmacy in Boutersem. Public Limited, started on 20 January 1987, 1 establishment.

What is the address of APOTHEEK STALPAERT?

The registered office of APOTHEEK STALPAERT is located at Lubbeeksestraat 17, 3370 Boutersem.

Is APOTHEEK STALPAERT still active?

Yes. According to the CBE (29 October 2026) APOTHEEK STALPAERT is active, legal situation “Normale toestand”, started on 20 January 1987.

Is APOTHEEK STALPAERT registered on Peppol?

Yes, APOTHEEK STALPAERT is registered on the Peppol network with ID 0208:0430355247.

What is the enterprise number of APOTHEEK STALPAERT?

The enterprise number of APOTHEEK STALPAERT is BE0430355247.

When was APOTHEEK STALPAERT founded?

APOTHEEK STALPAERT was founded on 20 January 1987.

Who are the directors of APOTHEEK STALPAERT?

According to the 2025 annual accounts, the directors of APOTHEEK STALPAERT are: Bellefarma BV, Leonardus Aerden.

Is APOTHEEK STALPAERT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 January 1987; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK STALPAERT make in 2025?

APOTHEEK STALPAERT posted a profit after taxes of € 157,633 in financial year 2025.

What is the revenue of APOTHEEK STALPAERT?

As a small company, APOTHEEK STALPAERT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 310,903.

How much does an employee at APOTHEEK STALPAERT earn?

The average wage cost per full-time employee at APOTHEEK STALPAERT was € 46,100 in 2025: staff costs of € 46,109 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK STALPAERT have?

According to the 2025 annual accounts, APOTHEEK STALPAERT has 1 full-time equivalents (FTE).

APOTHEEK STALPAERT (Public Limited) - Boutersem

Dossier APOTHEEK STALPAERT, printed on 29 October 2026 from databakkes.be/en/0430355247/apotheek-stalpaert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK STALPAERT from Boutersem, company number BE0430355247, closed financial year 2025 with a result of € 157,633 after tax. For that financial year APOTHEEK STALPAERT recorded a gross margin of € 310,903 and equity of € 137,094. Compared with financial year 2024, the result moved from € 162,496 to € 157,633. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2026.

What it is worth Growing

€ 137,094

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 157,633

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 228,988

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 157,000 paid out

100 % of the profit went to the shareholders, mostly to BELLEFARMA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 46,109

▲ 3% vs 2024

€ 46,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,856

▼ 1% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 85,378

▲ 108% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,221

▲ 37% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 262,408 Gross margin 2022: € 262,408 First fiscal year in the series	€ 292,257 Gross margin 2023: € 292,257 ▲ 11% vs 2022 (€ 262,408) Favourable step	€ 304,671 Gross margin 2024: € 304,671 ▲ 4% vs 2023 (€ 292,257) Favourable step	€ 310,903 Gross margin 2025: € 310,903 ▲ 2% vs 2024 (€ 304,671) Favourable step	▲ 2%
Profit after taxes	€ 149,758 Profit after taxes 2022: € 149,758 First fiscal year in the series	€ 174,745 Profit after taxes 2023: € 174,745 ▲ 17% vs 2022 (€ 149,758) Favourable step	€ 162,496 Profit after taxes 2024: € 162,496 ▼ 7% vs 2023 (€ 174,745) Unfavourable step	€ 157,633 Profit after taxes 2025: € 157,633 ▼ 3% vs 2024 (€ 162,496) Unfavourable step	▼ 3%
Equity	€ 135,719 Equity 2022: € 135,719 First fiscal year in the series	€ 135,964 Equity 2023: € 135,964 Unchanged (€ 135,719) Favourable step	€ 136,460 Equity 2024: € 136,460 Unchanged (€ 135,964) Favourable step	€ 137,094 Equity 2025: € 137,094 Unchanged (€ 136,460) Favourable step
Total debts	€ 683,256 Total debts 2022: € 683,256 First fiscal year in the series	€ 422,138 Total debts 2023: € 422,138 ▼ 38% vs 2022 (€ 683,256) Favourable step	€ 466,164 Total debts 2024: € 466,164 ▲ 10% vs 2023 (€ 422,138) Unfavourable step	€ 508,396 Total debts 2025: € 508,396 ▲ 9% vs 2024 (€ 466,164) Unfavourable step	▲ 9%
Cash	€ 296,381 Cash 2022: € 296,381 First fiscal year in the series	€ 78,960 Cash 2023: € 78,960 ▼ 73% vs 2022 (€ 296,381) Unfavourable step	€ 187,290 Cash 2024: € 187,290 ▲ 137% vs 2023 (€ 78,960) Favourable step	€ 228,988 Cash 2025: € 228,988 ▲ 22% vs 2024 (€ 187,290) Favourable step	▲ 22%
Land & buildings	€ 149,923 Land & buildings 2022: € 149,923 First fiscal year in the series	€ 112,342 Land & buildings 2023: € 112,342 ▼ 25% vs 2022 (€ 149,923) Unchanged	€ 77,447 Land & buildings 2024: € 77,447 ▼ 31% vs 2023 (€ 112,342) Unchanged	€ 42,552 Land & buildings 2025: € 42,552 ▼ 45% vs 2024 (€ 77,447) Unchanged	▼ 45%
Retained profit	€ 73,719 Retained profit 2022: € 73,719 First fiscal year in the series	€ 73,964 Retained profit 2023: € 73,964 Unchanged (€ 73,719) Favourable step	€ 74,460 Retained profit 2024: € 74,460 ▲ 1% vs 2023 (€ 73,964) Favourable step	€ 75,094 Retained profit 2025: € 75,094 ▲ 1% vs 2024 (€ 74,460) Favourable step	▲ 1%
Dividend	€ 149,500 Dividend 2022: € 149,500 First fiscal year in the series	€ 174,500 Dividend 2023: € 174,500 ▲ 17% vs 2022 (€ 149,500) Unchanged	€ 162,000 Dividend 2024: € 162,000 ▼ 7% vs 2023 (€ 174,500) Unchanged	€ 157,000 Dividend 2025: € 157,000 ▼ 3% vs 2024 (€ 162,000) Unchanged	▼ 3%
Bank debt	€ 73,386 Bank debt 2022: € 73,386 First fiscal year in the series	€ 13,501 Bank debt 2023: € 13,501 ▼ 82% vs 2022 (€ 73,386) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 13,501) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 818,975 Balance sheet total 2022: € 818,975 First fiscal year in the series	€ 558,102 Balance sheet total 2023: € 558,102 ▼ 32% vs 2022 (€ 818,975) Unchanged	€ 602,624 Balance sheet total 2024: € 602,624 ▲ 8% vs 2023 (€ 558,102) Unchanged	€ 645,490 Balance sheet total 2025: € 645,490 ▲ 7% vs 2024 (€ 602,624) Unchanged	▲ 7%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (1) Unchanged

Key figures of APOTHEEK STALPAERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK STALPAERT?

What happened at APOTHEEK STALPAERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Bellefarma BV stepped down as director. NBB
2028 Leonardus Aerden stepped down as director. NBB
Sep 23, 2026 New annual accounts for financial year 2025: profit of € 157,633 (▼ 3% vs 2024). filed late Source: NBB ↗
2022 Bellefarma BV became a director. NBB
2022 Leonardus Aerden became a director. NBB
Feb 20, 1987 New establishment in Boutersem. KBO
Jan 20, 1987 Start of the company according to the CBE. KBO

In short

From € 149,758 profit in 2022 to € 157,633 profit in 2025.

Paid € 96,333 in corporate taxes since 2022.

Best year ever: 2023, with € 174,745 profit.

On average € 310,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BELLEFARMA 99.9%

The stake of BELLEFARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK STALPAERT

The shares are held by BELLEFARMA (99.9%).

Directors

According to the 2025 annual accounts

Bellefarma BV

Managing director · represented by Isabella Stalpaert

since 2022 · until 2028

Leonardus Aerden

Director

Also active at: LICENTIA

since 2022 · until 2028

Shareholders

BELLEFARMA

99.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lubbeeksestraat 17

3370 Boutersem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

LICENTIA same network

€ 198,209 gross margin · 2025

BELLEFARMA same network

€ 112,957 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0430.355.247

VAT number

BE 0430.355.247

Registered office

Lubbeeksestraat 17, 3370 Boutersem

Names & denominations

APOTHEEK STALPAERT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

20 January 1987

Peppol

Active · Active since 18 Jul 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK STALPAERT

Financials

What happened to APOTHEEK STALPAERT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions